Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

This uterine fibroid treatment is underused despite being cost-effective

March 13, 2017 By Danielle Kirsh

uterine-fibroids-2

[Image from the U.S. Department of Health and Human Services]

A new study suggests that a minimally invasive, image-guided treatment for uterine fibroids is used a lot less than other surgical treatments.

Hysterectomies were performed 65 times more than the minimally invasive uterine fibroid embolization (UFE), which has even been proven to cost less and result in a shorter hospital stay.

“These findings suggest there is a lack of awareness about this safe, effective and less invasive therapy for uterine fibroids,” Dr. Prasoon Mohan, a University of Miami interventional radiology professor and the study’s lead author, said in a press release. “Interventional radiologists urge healthcare professionals to present patients with all available treatment options so that the patient can make an informed decision. Patients need to know about the major differences between surgical treatments and UFE, especially that this is a non-surgical treatment that preserves the uterus and has a much faster recovery time compared to a hysterectomy.”

Uterine fibroids are muscular tumors that grow on the wall of the uterus, according to the U.S. Department of Health and Human Services. They’re usually benign and grow as small as an apple seed to as big as a grapefruit. They are common in women who are in their 30s and 40s and those who are going through menopause. Fibroids shrink after menopause. Researchers are unsure what causes fibroids but think that it is caused by hormones or genetics.

UFE treatment involves a thin catheter being inserted into the artery at the groin or wrist. The interventional radiologist guides the catheter to the blood supply for the fibroid, and small, sand-like particles float down the bloodstream to block the blood vessel of the fibroid from receiving any nutrients. This makes the fibroid soften, shrink and bleed less. 9 out of 10 women who receive this treatment report having their symptoms disappear completely.

The study analyzed Nationwide Inpatient Sample data from 2012 and 2013 and the researchers compared how many women were treated with UFE as opposed to receiving a hysterectomy, how much it cost for the treatment and what the outcomes were.

The data showed that 165,000 more hysterectomies than UFE were performed in 2012 and 2013. 0.4% of UFEs were performed in rural and smaller hospitals whereas 9.4% of uterine fibroids was treated with a hysterectomy. 7.9% of UFE treatments were performed in small hospitals and 67.4% were performed in larger hospitals.

“The fact that so few women undergo UFE in rural and small hospital settings shows a healthcare access and education disparity in who receives this treatment. It is important that we continue to educate patients about choice and determine ways to increase access to this effective, less invasive therapy,” said Mohan, who is also an assistant professor in the department of interventional radiology at the University of Miami Leonard M. Miller School of Medicine.

UFE treatment also showed that the shorter hospital stays were more cost-effective than receiving a hysterectomy – showing a $12,000 difference.

The study, titled “Nationwide analysis of hospital characteristics, demographics and cost of uterine fibroid embolization,” was published online on the Society of Interventional Radiology’s website.

[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]

About The Author

Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Related Articles Read More >

Illustration of MIT’s bone-anchored bionic knee: powered prosthetic leg, amputee using the device to walk and step over an obstacle, and cross-sections of thigh muscles showing electrodes and a titanium implant connecting nerves and bone.
Bionic knee wired to muscle nerves helps amputees clear obstacles, climb stairs
Carnegie Mellon University EEG-based BCI to control robotic hand
Non-invasive BCI enables robotic hand dexterity
Digital twins
How digital twins could advance cancer care
MassGeneralBrigham
Mass General Brigham research finds pulse rate could predict cognitive decline
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe